Hostile takeover? Daimler CEO says no fears about Chinese magnate Li Shufu
April 25, 2018SoftBank to move ride-hailing stakes worth $20 billion to Vision Fund: FT
April 25, 2018Shire willing to back $64 billion Takeda bid but market signals doubts
at
LONDON/NEW YORK/TOKYO (Reuters) – Rare disease specialist Shire said on Wednesday it was willing to recommend a sweetened $64 billion offer from Japan’s Takeda Pharmaceutical Co to shareholders, in what would be the biggest acquisition of a drug company this year.
Powered by WPeMatico
